Evidence map›Paper›PMID 25834397›Full record

SynthesisDrug design, development and therapy2015

Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysis.

Hui Shi, Tao Guo, Peng-Cheng Liu, Qian-Yi Wang, Ya-Ru Du, Qing-Yu Liu, Meng-Mei He, Jun-Ling Liu, Jing Yu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Drug design, development and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hui ShiDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China ; Department of First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Tao GuoDepartment of Ophthalmology, Shanghai Third People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Peng-Cheng LiuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Qian-Yi WangDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Ya-Ru DuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China ; Department of First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Qing-Yu LiuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Meng-Mei HeDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Jun-Ling LiuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Jing YuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Nanjing, Jiangsu, People's Republic of China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis meta-analysis was performed to determine the effectiveness of steroids as an adjunct following rhegmatogenous retinal detachment (RRD) surgery.

methodsRRD patients with or without proliferative vitreoretinopathy (PVR) were included. The treatment group included patients in whom steroids were used as an adjunct and a control group in which placebo was used. Only randomized controlled trials were included. We searched the main electronic databases and included studies published until July 2014. PVR odds ratio, visual acuity, retinal reattachment rate, and complications were evaluated in three trials.

resultsThree randomized controlled trials were included in the meta-analysis. There was no significant difference in the incidence of postoperative PVR between groups (heterogeneity I (2)=48%, P=0.14). However, the incidence of postoperative PVR was lower in the treatment group (I (2)=0%, P<0.0001) than in the control group when a PVR grade C study was excluded. There was no statistically significant difference in postoperative visual acuity between the treatment and control groups (odds ratio -0.18; 95% confidence interval -0.38, 0.02; P=0.08). The two groups had similar results for primary/final retinal reattachment and reoperation rate. There was no significant difference in postoperative intraocular pressure.

conclusionThis systematic review demonstrates that steroids may significantly reduce the incidence of postoperative PVR grade B or lower following RRD surgery.

Indexed as

HumansRandomized Controlled Trials as TopicRetinal DetachmentSteroidsVitreoretinopathy, ProliferativeSteroidsmeta-analysisproliferative vitreoretinopathysteroids

Identifiers

PMID25834397
PMCPMC4358646
OpenAlexW2084332067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.